Newsletters

We produce MPN Life newsletter which includes the latest in research, patient tips, health care and fundraising updates as well as other items of interest to the MPN community.

Want to keep up to date? Download our MPN Life newsletters.

If you would like to be featured in our patient stories contact info@mpnvoice.org.uk.

  • February 2012

    The day was packed with talks covering the individual MPD conditions, treatments and the latest medical options as well as fascinating updates on the... Download Newsletter »

  • May 2011

    Researchers have reported the results of the first JAK inhibitor study in Europe, and there is good news: the results were very positive. Download Newsletter »

  • September 2010

    Fifteen years after learning he had polycythaemia vera (PV), a patient has found in the last few years that his red cell counts have increased, requiring... Download Newsletter »

  • April 2010

    Five years ago we made several discoveries crucial to our understanding of myeloproliferative diseases. W Download Newsletter »

  • December 2009

    Is it better to test positive or negative for the JAK2 mutation? It’s a question we often hear from people with MPDs. Download Newsletter »

  • July 2009

    Several new drug studies will open in the UK over the next few months to test promising treatments for myeloproliferative disorders (MPDs). Download Newsletter »

  • December 2008

    Many people with MPDs test positive for a mutation in a molecule called JAK2. Researchers believe that inhibiting JAK2 will be the most promising path... Download Newsletter »

  • October 2007

    The discovery of the JAK2 V617F mutation in 2005 has triggered an explosion in research into myeloproliferative disorders (MPD). Download Newsletter »

  • September 2006

    The discovery of the JAK2 V617F mutation in 2005 has triggered an explosion in research into myeloproliferative disorders (MPD). Download Newsletter »

1 2